Drug Approvals Analysis

Novo wins UK approval as race to launch weight-loss pill intensifies

obesity · 6 min

AI in Drug Discovery Examples: What’s Changed Beyond Early Use Cases

FDA · 7 min

Federal Court Litigation on Reproductive Health: Rare Disease Implications

FDA · rare disease · 5 min

EC nod for Chiesi Lojuxta for pediatric HoFH: what it means for pharma

European Commission (EC) · rare disease · 5 min

European Cancer Guidelines Add Delcath Liver Therapy for Eye Melanoma

oncology · 5 min

FDA Voucher Program Pause Urged: Rare Disease Policy Analysis

FDA · rare disease · 5 min

Moderna Stock Rises as EMA Committee Backs New RSV Vaccine: Key Implications for Investors and BD Teams

EMA · 5 min

데일리팜 리크루트: Vyloy (zolbetuximab) Reimbursement Progress and Market Implications for Gastric Cancer

gastric cancer · 7 min

Florian Lordick Elected ESMO President 2029–2030: What Pharma Teams Should Watch

oncology · 6 min

From Approval to Access: Europe’s Next Health Imperative for Pharma

EMA · 9 min

Pharma People on the Move: Spring 2026 Roundup — Regulatory Updates

EMA · 6 min

Cellectar Biosciences (CLRB) FDA Approvals, PDUFA Dates & Drug Alerts 2026

FDA · 5 min